 | • レポートコード：MRC2-11QY05500 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はジストロフィンのグローバル市場について調査・分析したレポートです。種類別（DS-5141、ビオストロフィン、BMBD-001、NS-065、その他）市場規模、用途別（遺伝性疾患、筋骨格系障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ジストロフィンの競争状況、市場シェア ・世界のジストロフィン市場：種類別市場規模 2015年-2020年（DS-5141、ビオストロフィン、BMBD-001、NS-065、その他） ・世界のジストロフィン市場：種類別市場規模予測 2021年-2026年（DS-5141、ビオストロフィン、BMBD-001、NS-065、その他） ・世界のジストロフィン市場：用途別市場規模 2015年-2020年（遺伝性疾患、筋骨格系障害、その他） ・世界のジストロフィン市場：用途別市場規模予測 2021年-2026年（遺伝性疾患、筋骨格系障害、その他） ・北米のジストロフィン市場分析：米国、カナダ ・ヨーロッパのジストロフィン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのジストロフィン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のジストロフィン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのジストロフィン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Asklepios BioPharmaceutical Inc、BioMarin Pharmaceutical Inc、Daiichi Sankyo Company Ltd、Editas Medicine Inc、Genethon SA、Nippon Shinyaku Co Ltd、Pfizer Inc、Sarepta Therapeutics Inc、WAVE Life Sciences Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Dystrophin Market
The global Dystrophin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dystrophin Scope and Market Size
Dystrophin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dystrophin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dystrophin market is segmented into
DS-5141
Biostrophin
BMBD-001
NS-065
Others
Segment by Application, the Dystrophin market is segmented into
Genetic Disorders
Musculoskeletal Disorders
Others
Regional and Country-level Analysis
The Dystrophin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dystrophin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dystrophin Market Share Analysis
Dystrophin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dystrophin business, the date to enter into the Dystrophin market, Dystrophin product introduction, recent developments, etc.
The major vendors covered:
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
1 Study Coverage
1.1 Dystrophin Product Introduction
1.2 Market Segments
1.3 Key Dystrophin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dystrophin Market Size Growth Rate by Type
1.4.2 DS-5141
1.4.3 Biostrophin
1.4.4 BMBD-001
1.4.5 NS-065
1.4.6 Others
1.5 Market by Application
1.5.1 Global Dystrophin Market Size Growth Rate by Application
1.5.2 Genetic Disorders
1.5.3 Musculoskeletal Disorders
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dystrophin Market Size, Estimates and Forecasts
2.1.1 Global Dystrophin Revenue 2015-2026
2.1.2 Global Dystrophin Sales 2015-2026
2.2 Global Dystrophin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dystrophin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dystrophin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dystrophin Competitor Landscape by Players
3.1 Dystrophin Sales by Manufacturers
3.1.1 Dystrophin Sales by Manufacturers (2015-2020)
3.1.2 Dystrophin Sales Market Share by Manufacturers (2015-2020)
3.2 Dystrophin Revenue by Manufacturers
3.2.1 Dystrophin Revenue by Manufacturers (2015-2020)
3.2.2 Dystrophin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dystrophin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dystrophin Revenue in 2019
3.2.5 Global Dystrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dystrophin Price by Manufacturers
3.4 Dystrophin Manufacturing Base Distribution, Product Types
3.4.1 Dystrophin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dystrophin Product Type
3.4.3 Date of International Manufacturers Enter into Dystrophin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dystrophin Market Size by Type (2015-2020)
4.1.1 Global Dystrophin Sales by Type (2015-2020)
4.1.2 Global Dystrophin Revenue by Type (2015-2020)
4.1.3 Dystrophin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dystrophin Market Size Forecast by Type (2021-2026)
4.2.1 Global Dystrophin Sales Forecast by Type (2021-2026)
4.2.2 Global Dystrophin Revenue Forecast by Type (2021-2026)
4.2.3 Dystrophin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dystrophin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dystrophin Market Size by Application (2015-2020)
5.1.1 Global Dystrophin Sales by Application (2015-2020)
5.1.2 Global Dystrophin Revenue by Application (2015-2020)
5.1.3 Dystrophin Price by Application (2015-2020)
5.2 Dystrophin Market Size Forecast by Application (2021-2026)
5.2.1 Global Dystrophin Sales Forecast by Application (2021-2026)
5.2.2 Global Dystrophin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dystrophin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dystrophin by Country
6.1.1 North America Dystrophin Sales by Country
6.1.2 North America Dystrophin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dystrophin Market Facts & Figures by Type
6.3 North America Dystrophin Market Facts & Figures by Application
7 Europe
7.1 Europe Dystrophin by Country
7.1.1 Europe Dystrophin Sales by Country
7.1.2 Europe Dystrophin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dystrophin Market Facts & Figures by Type
7.3 Europe Dystrophin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dystrophin by Region
8.1.1 Asia Pacific Dystrophin Sales by Region
8.1.2 Asia Pacific Dystrophin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dystrophin Market Facts & Figures by Type
8.3 Asia Pacific Dystrophin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dystrophin by Country
9.1.1 Latin America Dystrophin Sales by Country
9.1.2 Latin America Dystrophin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dystrophin Market Facts & Figures by Type
9.3 Central & South America Dystrophin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dystrophin by Country
10.1.1 Middle East and Africa Dystrophin Sales by Country
10.1.2 Middle East and Africa Dystrophin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dystrophin Market Facts & Figures by Type
10.3 Middle East and Africa Dystrophin Market Facts & Figures by Application
11 Company Profiles
11.1 Asklepios BioPharmaceutical Inc
11.1.1 Asklepios BioPharmaceutical Inc Corporation Information
11.1.2 Asklepios BioPharmaceutical Inc Description and Business Overview
11.1.3 Asklepios BioPharmaceutical Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Asklepios BioPharmaceutical Inc Dystrophin Products Offered
11.1.5 Asklepios BioPharmaceutical Inc Related Developments
11.2 BioMarin Pharmaceutical Inc
11.2.1 BioMarin Pharmaceutical Inc Corporation Information
11.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
11.2.3 BioMarin Pharmaceutical Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioMarin Pharmaceutical Inc Dystrophin Products Offered
11.2.5 BioMarin Pharmaceutical Inc Related Developments
11.3 Daiichi Sankyo Company Ltd
11.3.1 Daiichi Sankyo Company Ltd Corporation Information
11.3.2 Daiichi Sankyo Company Ltd Description and Business Overview
11.3.3 Daiichi Sankyo Company Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daiichi Sankyo Company Ltd Dystrophin Products Offered
11.3.5 Daiichi Sankyo Company Ltd Related Developments
11.4 Editas Medicine Inc
11.4.1 Editas Medicine Inc Corporation Information
11.4.2 Editas Medicine Inc Description and Business Overview
11.4.3 Editas Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Editas Medicine Inc Dystrophin Products Offered
11.4.5 Editas Medicine Inc Related Developments
11.5 Genethon SA
11.5.1 Genethon SA Corporation Information
11.5.2 Genethon SA Description and Business Overview
11.5.3 Genethon SA Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Genethon SA Dystrophin Products Offered
11.5.5 Genethon SA Related Developments
11.6 Nippon Shinyaku Co Ltd
11.6.1 Nippon Shinyaku Co Ltd Corporation Information
11.6.2 Nippon Shinyaku Co Ltd Description and Business Overview
11.6.3 Nippon Shinyaku Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nippon Shinyaku Co Ltd Dystrophin Products Offered
11.6.5 Nippon Shinyaku Co Ltd Related Developments
11.7 Pfizer Inc
11.7.1 Pfizer Inc Corporation Information
11.7.2 Pfizer Inc Description and Business Overview
11.7.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Inc Dystrophin Products Offered
11.7.5 Pfizer Inc Related Developments
11.8 Sarepta Therapeutics Inc
11.8.1 Sarepta Therapeutics Inc Corporation Information
11.8.2 Sarepta Therapeutics Inc Description and Business Overview
11.8.3 Sarepta Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sarepta Therapeutics Inc Dystrophin Products Offered
11.8.5 Sarepta Therapeutics Inc Related Developments
11.9 WAVE Life Sciences Ltd
11.9.1 WAVE Life Sciences Ltd Corporation Information
11.9.2 WAVE Life Sciences Ltd Description and Business Overview
11.9.3 WAVE Life Sciences Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 WAVE Life Sciences Ltd Dystrophin Products Offered
11.9.5 WAVE Life Sciences Ltd Related Developments
11.1 Asklepios BioPharmaceutical Inc
11.1.1 Asklepios BioPharmaceutical Inc Corporation Information
11.1.2 Asklepios BioPharmaceutical Inc Description and Business Overview
11.1.3 Asklepios BioPharmaceutical Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Asklepios BioPharmaceutical Inc Dystrophin Products Offered
11.1.5 Asklepios BioPharmaceutical Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dystrophin Market Estimates and Projections by Region
12.1.1 Global Dystrophin Sales Forecast by Regions 2021-2026
12.1.2 Global Dystrophin Revenue Forecast by Regions 2021-2026
12.2 North America Dystrophin Market Size Forecast (2021-2026)
12.2.1 North America: Dystrophin Sales Forecast (2021-2026)
12.2.2 North America: Dystrophin Revenue Forecast (2021-2026)
12.2.3 North America: Dystrophin Market Size Forecast by Country (2021-2026)
12.3 Europe Dystrophin Market Size Forecast (2021-2026)
12.3.1 Europe: Dystrophin Sales Forecast (2021-2026)
12.3.2 Europe: Dystrophin Revenue Forecast (2021-2026)
12.3.3 Europe: Dystrophin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dystrophin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dystrophin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dystrophin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dystrophin Market Size Forecast by Region (2021-2026)
12.5 Latin America Dystrophin Market Size Forecast (2021-2026)
12.5.1 Latin America: Dystrophin Sales Forecast (2021-2026)
12.5.2 Latin America: Dystrophin Revenue Forecast (2021-2026)
12.5.3 Latin America: Dystrophin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dystrophin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dystrophin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dystrophin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dystrophin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dystrophin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dystrophin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dystrophin Market Segments
Table 2. Ranking of Global Top Dystrophin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dystrophin Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of DS-5141
Table 5. Major Manufacturers of Biostrophin
Table 6. Major Manufacturers of BMBD-001
Table 7. Major Manufacturers of NS-065
Table 8. Major Manufacturers of Others
Table 9. Global Dystrophin Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Dystrophin Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Dystrophin Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Dystrophin Sales Market Share by Regions (2015-2020)
Table 13. Global Dystrophin Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Dystrophin Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Dystrophin Sales Share by Manufacturers (2015-2020)
Table 16. Global Dystrophin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Dystrophin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dystrophin as of 2019)
Table 18. Dystrophin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Dystrophin Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Dystrophin Price (2015-2020) (USD/Pcs)
Table 21. Dystrophin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dystrophin Product Type
Table 23. Date of International Manufacturers Enter into Dystrophin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 26. Global Dystrophin Sales Share by Type (2015-2020)
Table 27. Global Dystrophin Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Dystrophin Revenue Share by Type (2015-2020)
Table 29. Dystrophin Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 31. Global Dystrophin Sales Share by Application (2015-2020)
Table 32. North America Dystrophin Sales by Country (2015-2020) (K Pcs)
Table 33. North America Dystrophin Sales Market Share by Country (2015-2020)
Table 34. North America Dystrophin Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Dystrophin Revenue Market Share by Country (2015-2020)
Table 36. North America Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 37. North America Dystrophin Sales Market Share by Type (2015-2020)
Table 38. North America Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 39. North America Dystrophin Sales Market Share by Application (2015-2020)
Table 40. Europe Dystrophin Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Dystrophin Sales Market Share by Country (2015-2020)
Table 42. Europe Dystrophin Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Dystrophin Revenue Market Share by Country (2015-2020)
Table 44. Europe Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Dystrophin Sales Market Share by Type (2015-2020)
Table 46. Europe Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Dystrophin Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Dystrophin Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Dystrophin Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Dystrophin Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Dystrophin Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Dystrophin Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Dystrophin Sales Market Share by Application (2015-2020)
Table 56. Latin America Dystrophin Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Dystrophin Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Dystrophin Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Dystrophin Revenue Market Share by Country (2015-2020)
Table 60. Latin America Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Dystrophin Sales Market Share by Type (2015-2020)
Table 62. Latin America Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Dystrophin Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Dystrophin Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Dystrophin Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Dystrophin Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Dystrophin Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dystrophin Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Dystrophin Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Dystrophin Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Dystrophin Sales Market Share by Application (2015-2020)
Table 72. Asklepios BioPharmaceutical Inc Corporation Information
Table 73. Asklepios BioPharmaceutical Inc Description and Major Businesses
Table 74. Asklepios BioPharmaceutical Inc Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Asklepios BioPharmaceutical Inc Product
Table 76. Asklepios BioPharmaceutical Inc Recent Development
Table 77. BioMarin Pharmaceutical Inc Corporation Information
Table 78. BioMarin Pharmaceutical Inc Description and Major Businesses
Table 79. BioMarin Pharmaceutical Inc Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. BioMarin Pharmaceutical Inc Product
Table 81. BioMarin Pharmaceutical Inc Recent Development
Table 82. Daiichi Sankyo Company Ltd Corporation Information
Table 83. Daiichi Sankyo Company Ltd Description and Major Businesses
Table 84. Daiichi Sankyo Company Ltd Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Daiichi Sankyo Company Ltd Product
Table 86. Daiichi Sankyo Company Ltd Recent Development
Table 87. Editas Medicine Inc Corporation Information
Table 88. Editas Medicine Inc Description and Major Businesses
Table 89. Editas Medicine Inc Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Editas Medicine Inc Product
Table 91. Editas Medicine Inc Recent Development
Table 92. Genethon SA Corporation Information
Table 93. Genethon SA Description and Major Businesses
Table 94. Genethon SA Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Genethon SA Product
Table 96. Genethon SA Recent Development
Table 97. Nippon Shinyaku Co Ltd Corporation Information
Table 98. Nippon Shinyaku Co Ltd Description and Major Businesses
Table 99. Nippon Shinyaku Co Ltd Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Nippon Shinyaku Co Ltd Product
Table 101. Nippon Shinyaku Co Ltd Recent Development
Table 102. Pfizer Inc Corporation Information
Table 103. Pfizer Inc Description and Major Businesses
Table 104. Pfizer Inc Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Pfizer Inc Product
Table 106. Pfizer Inc Recent Development
Table 107. Sarepta Therapeutics Inc Corporation Information
Table 108. Sarepta Therapeutics Inc Description and Major Businesses
Table 109. Sarepta Therapeutics Inc Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Sarepta Therapeutics Inc Product
Table 111. Sarepta Therapeutics Inc Recent Development
Table 112. WAVE Life Sciences Ltd Corporation Information
Table 113. WAVE Life Sciences Ltd Description and Major Businesses
Table 114. WAVE Life Sciences Ltd Dystrophin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. WAVE Life Sciences Ltd Product
Table 116. WAVE Life Sciences Ltd Recent Development
Table 117. Global Dystrophin Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Dystrophin Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Dystrophin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Dystrophin Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Dystrophin Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Dystrophin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Dystrophin Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Dystrophin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Dystrophin Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Dystrophin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Dystrophin Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Dystrophin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Dystrophin Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Dystrophin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Dystrophin Players
Table 135. Dystrophin Customers List
Table 136. Dystrophin Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Dystrophin Product Picture
Figure 2. Global Dystrophin Sales Market Share by Type in 2020 & 2026
Figure 3. DS-5141 Product Picture
Figure 4. Biostrophin Product Picture
Figure 5. BMBD-001 Product Picture
Figure 6. NS-065 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Dystrophin Sales Market Share by Application in 2020 & 2026
Figure 9. Genetic Disorders
Figure 10. Musculoskeletal Disorders
Figure 11. Others
Figure 12. Dystrophin Report Years Considered
Figure 13. Global Dystrophin Market Size 2015-2026 (US$ Million)
Figure 14. Global Dystrophin Sales 2015-2026 (K Pcs)
Figure 15. Global Dystrophin Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Dystrophin Sales Market Share by Region (2015-2020)
Figure 17. Global Dystrophin Sales Market Share by Region in 2019
Figure 18. Global Dystrophin Revenue Market Share by Region (2015-2020)
Figure 19. Global Dystrophin Revenue Market Share by Region in 2019
Figure 20. Global Dystrophin Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Dystrophin Revenue in 2019
Figure 22. Dystrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Dystrophin Sales Market Share by Type (2015-2020)
Figure 24. Global Dystrophin Sales Market Share by Type in 2019
Figure 25. Global Dystrophin Revenue Market Share by Type (2015-2020)
Figure 26. Global Dystrophin Revenue Market Share by Type in 2019
Figure 27. Global Dystrophin Market Share by Price Range (2015-2020)
Figure 28. Global Dystrophin Sales Market Share by Application (2015-2020)
Figure 29. Global Dystrophin Sales Market Share by Application in 2019
Figure 30. Global Dystrophin Revenue Market Share by Application (2015-2020)
Figure 31. Global Dystrophin Revenue Market Share by Application in 2019
Figure 32. North America Dystrophin Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Dystrophin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Dystrophin Sales Market Share by Country in 2019
Figure 35. North America Dystrophin Revenue Market Share by Country in 2019
Figure 36. U.S. Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Dystrophin Market Share by Type in 2019
Figure 41. North America Dystrophin Market Share by Application in 2019
Figure 42. Europe Dystrophin Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Dystrophin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Dystrophin Sales Market Share by Country in 2019
Figure 45. Europe Dystrophin Revenue Market Share by Country in 2019
Figure 46. Germany Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Dystrophin Market Share by Type in 2019
Figure 57. Europe Dystrophin Market Share by Application in 2019
Figure 58. Asia Pacific Dystrophin Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Dystrophin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Dystrophin Sales Market Share by Region in 2019
Figure 61. Asia Pacific Dystrophin Revenue Market Share by Region in 2019
Figure 62. China Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Dystrophin Market Share by Type in 2019
Figure 85. Asia Pacific Dystrophin Market Share by Application in 2019
Figure 86. Latin America Dystrophin Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Dystrophin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Dystrophin Sales Market Share by Country in 2019
Figure 89. Latin America Dystrophin Revenue Market Share by Country in 2019
Figure 90. Mexico Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Dystrophin Market Share by Type in 2019
Figure 97. Latin America Dystrophin Market Share by Application in 2019
Figure 98. Middle East and Africa Dystrophin Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Dystrophin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Dystrophin Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Dystrophin Revenue Market Share by Country in 2019
Figure 102. Turkey Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Dystrophin Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Dystrophin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Dystrophin Market Share by Type in 2019
Figure 109. Middle East and Africa Dystrophin Market Share by Application in 2019
Figure 110. North America Dystrophin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Dystrophin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Dystrophin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Dystrophin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Dystrophin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Dystrophin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Dystrophin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Dystrophin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Dystrophin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Dystrophin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
遺伝性疾患薬の世界市場（～2026年） Market Analysis and Insights: Global Genetic Disorders Drug Market The global Genetic Disorders Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genetic Disorders Drug Scope and Market Size Genetic Disorders Drug m…- パニック障害の世界市場（～2026年） Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used inc…
- 神経精神障害・治療の世界市場（～2026年） Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…
- 副甲状腺障害の世界市場（～2026年） Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems. Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hy…
- 膝・股関節障害の世界市場（～2026年） Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …